Five things to know:
1. During the fourth quarter, the company reported relatively flat orthopedics sales at $2.2 billion. U.S. sales grew 0.9 percent to $1.3 billion while international sales were flat at $904 million.
2. Worldwide hip sales were up 1.4 percent last year, hitting $1.4 billion. For the fourth quarter, hip sales jumped 3.4 percent to $377 million, with U.S. hip sales increasing nearly 5 percent.
3. Knee sales were down for the full year, dropping 1.4 percent to $1.4 billion. During the fourth quarter, knee sales were up 0.7 percent to $395 million, with U.S. sales remaining flat at $239 million.
4. Spine and other sales were down 2 percent worldwide in 2019, hitting $3.2 billion. The fourth quarter spine and other sales were down 1.8 percent, driven by international declines. U.S. spine and other sales also declined 1.6 percent to $488 million.
5. Worldwide trauma sales were up 0.8 percent last year, hitting $2.7 million. Fourth quarter U.S. trauma sales were up 2.3 percent to $413 million, and overall trauma sales were up 1.7 percent during the fourth quarter, hitting $686 million.
More articles on orthopedic devices:
Life Spine reports double-digit revenue growth, 7 new FDA gains in 2019
NuVasive, Alphatec report preliminary 2019 results & more: 11 device company notes
4 big devicemakers rival Intuitive Surgical in robotics — Medtronic, Stryker & more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.